Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and <scp>JAK</scp> inhibitors: A case series
Niccolò Gori(Università Cattolica del Sacro Cuore), Luca Bianchi(University of Rome Tor Vergata), Angelo Valerio Marzano(University of Milan), Simone Ribero, Giampiero Girolomoni(University of Verona), Andrea Chiricozzi(Università Cattolica del Sacro Cuore), Lucia Di Nardo(Università Cattolica del Sacro Cuore), Giulia Coscarella(Università Cattolica del Sacro Cuore), Mónica Munera‐Campos(Hospital Universitari Germans Trias i Pujol), Curdin Conrad(University of Lausanne), Marco Galluzzo(University of Rome Tor Vergata), Anna Balato(University of Campania "Luigi Vanvitelli"), J.M. Carrascosa(Hospital Universitari Germans Trias i Pujol), Michela Ortoncelli, Teofila Seremet(University of Lausanne), Giuseppe Argenziano(Regione Campania), Flaminia Antonelli(Università Cattolica del Sacro Cuore), Silvia Mariel Ferrucci(University of Milan), Ketty Peris(Università Cattolica del Sacro Cuore), Martina Maurelli(University of Verona), Elena Ippoliti(Università Cattolica del Sacro Cuore)
Cited by 10
Related Papers
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
|Clinical Reviews in Allergy & Immunology|2018|738
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions
|The Journal of Immunology|2001|553
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
|Journal of the European Academy of Dermatology and Venereology|2022|419
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332